Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Memorial Sloan Kettering Cancer Center
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Adult patient \> 18 years old
Biopsy-proven metastatic ILC
Confirmed ER+ breast cancer from either primary tumor or metastatic biopsy (ER receptor percent staining ≥ 10% of tumor cells by IHC)
HER2-negative per ASCO/CAP
ECOG Performance Status Score of 0, 1 or 2.
Patient can have received up to 2 lines of therapy in the metastatic setting
Life expectancy of at least 12 months
You may not be if
Low ER expression defined as ER \<10% of tumor cells by IHC
Patients who have been on adjuvant ER-blocking endocrine therapy with SERM or SERD without an 8- and 24-weeks washout, respectively. (The use of aromatase inhibitors or ovarian suppression is permitted given that they do not block estrogen receptors).
Pregnancy or lactation or parturient or nursing mother
Patient presents with any other clinically active, serious, life-threatening disease, medical, or psychiatric condition, and/or who has a life expectancy of \<12 months, or for whom study participation may compromise their management; and/or a patient who the investigator judges to be unsuitable for participation in the study for any reason.
Clareo Health | A Study Comparing Cancer Imaging Approaches in People With Lobular Breast Cancer
